Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Nutriband stock last closed at $7.39, up 2.5% from the previous day, and has increased 36.35% in one year. It has overperformed other stocks in the Biotechnology industry by 1.02 percentage points. Nutriband stock is currently +98.55% from its 52-week low of $3.72, and -37.27% from its 52-week high of $11.78.
As of Aug 1, 2025, there are 11.15M shares of NTRB outstanding. The market capitalization of NTRB is $82.43M. In the past 24 hours, 14,000 NTRB shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy NTRB stock.
Based on our experience, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal information so you are able to invest in NTRB today.
Now that you have finished signing up on app for investing, you can securely and quickly fund your account:
Check out the tutorial below for more details depositing funds into your brokerage account.
After you have chosen the best place to buy Nutriband stock, it's important to research their stock prior to investing, so you can understand the risk and upside.
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on NTRB's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NTRB's true value.
Using relative valuations ratios:
You can do additional valuation analysis on NTRB's stock here.
You can dive deeper into what analysts are forecasting on the Nutriband stock forecast page.
Last year, NTRB revenue was $2.40M. During the past 5 year, NTRB's revenue has grown by 51.92% per year. This was faster than the Biotechnology industry average of 45.22%.
You can research NTRB's earnings and revenue performance here.
In the past year, insiders at NTRB have not bought or sold any shares.
Get more info about who owns NTRB shares here.
No, Nutriband doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two main options:
Press the Open button and your broker will execute the order.
If you require additional help with buying stocks on eToro, click the helpful video below:
Now that you own some NTRB shares, you'll want to stay up-to-date on your new company.
Put NTRB on a watchlist to get the latest updates about your NTRB stock.
To summarize, here are the 6 steps to buy Nutriband stock:
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Nutriband, add NTRB to your watchlist by clicking the button below.